| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.11B | -34.8% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | -70.6% |
| Gross margin | 41.0% | Net margin 11.2% |
| Revenue Q/Q | -75.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.06B | 59.0% |
| R&D | ¥0.01B | 10.0% |
| SG&A | ¥0.03B | 27.1% |
| Tax & other | ¥-0.00B | -0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
西部牧业 ・ 建新股份 ・ 新开源 ・ 华仁药业 ・ 向日葵 ・ 万讯自控 ・ 顺网科技 ・ 长盈精密 ・ 东方日升 ・ 瑞普生物 ・ 经纬辉开 ・ 阳谷华泰
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies